Showcase Posts

The scoop: After years operating under the radar, Ansun Biopharma (formerly NexBio) is building momentum behind a portfolio of biologic drugs for viral infections, headlined by DAS181, a first-in-class therapy in midstage...

SAN DIEGO, May 14, 2018 /PRNewswire/ -- Ansun BioPharma, Inc., a leading biotechnology company focused on the development of novel broad spectrum anti-viral biologic therapeutics to combat severe viral respiratory tract infections,...